The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 1/Signature 2
From BugSigDB
Reviewed Marked as Reviewed by Folakunmi on 2024-4-9
Source: Fig. 3A, Supp. Table S6
Description: Differential abundance between responders and non-responders to Anti–PD-1/PD-L1 Immunotherapy in all 74 patients with Gastrointestinal Cancer
Abundance in Group 1: decreased abundance in Responders to anti–PD-1/PD-L1 immunotherapy
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroides | ||
| Catenibacterium | ||
| Hungatella | ||
| Ruminococcus_2Ruminococcus_2 | ||
| Ruminococcaceae NK4A214 groupRuminococcaceae NK4A214 group | ||
| uncultured Oscillospiraceae bacterium |
Revision editor(s): Hamza, Scholastica
